Globus Medical, Inc. (BMV:GMED)

Market Cap	201.45B -21.2%
Revenue (ttm)	50.80B +11.7%
Net Income	7.77B +363.1%
EPS	56.48 +358.9%
Shares Out	n/a
PE Ratio	25.92
Forward PE	20.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Average Volume	614
Open	1,650.00
Previous Close	1,557.69
Day's Range	1,650.00 - 1,650.00
52-Week Range	991.50 - 1,888.19
Beta	n/a
RSI	60.32
Earnings Date	Feb 24, 2026

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip a...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 5,300
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: GMED

Financial Performance

In 2024, Globus Medical's revenue was $2.52 billion, an increase of 60.62% compared to the previous year's $1.57 billion. Earnings were $102.98 million, a decrease of -16.19%.

Financial numbers in USD